Pfizer Inc. reports $14.45 billion revenue for quarter ended March 29, 2026, up 5.4%
Pfizer Inc. reported revenue of $14.45 billion for the quarter ended March 29, 2026, an increase of 5.4% from the same quarter a year earlier ($13.71 billion).
For the same period it posted net income of $2.69 billion, down 9.4%, or $0.47 per diluted share (0.52 a year earlier).
That is a net margin of 18.6%.
On Sanad's AAOIFI Standard 21 screen, Pfizer Inc. is currently not compliant: interest-bearing debt is 38.6% of market capitalisation (limit 30%), and impure income is 1% of revenue (limit 5%).
Is Pfizer Inc. halal?
See the full AAOIFI screening of Pfizer Inc.
See the full AAOIFI screening of Pfizer Inc.
Source: 10-Q filed with the U.S. Securities and Exchange Commission on May 5, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.